IAN F SMITH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for IAN F SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of IAN F SMITH. IAN F SMITH is EVP & CFO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, CFO & COO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, COO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP & CFO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in ACORDA THERAPEUTICS INC ($ACOR) and Director in Ophthotech Corp. ($OPHT) and Director in Solid Biosciences Inc. ($SLDB) and in Foghorn Therapeutics Inc. ($FHTX).
Latest Insider Trading Transactions of IAN F SMITH
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACOR, FHTX, INFI, OPHT, SLDB, VRTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | FHTX | Foghorn Therapeuti ... | SMITH IAN F | Option Exercise | A | 11.50 | 25,060 | 288,190 | 25,060 | ||
| Jan 06 2021 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Option Exercise | A | 7.84 | 389,000 | 3,049,760 | 389,000 | |
| Dec 14 2020 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Grant | A | 3.70 | 270,270 | 999,999 | 270,270 | 0 to 270.3 K |
| Jun 18 2020 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Option Exercise | A | 3.03 | 200,000 | 606,000 | 200,000 | |
| Apr 16 2020 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Option Exercise | A | 2.49 | 40,000 | 99,600 | 40,000 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 131.89 | 23,375 | 3,082,929 | 10,625 | |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 166.57 | 18,634 | 3,103,865 | 46,699 | 65.3 K to 46.7 K (-28.52 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 165.22 | 4,741 | 783,308 | 65,333 | 70.1 K to 65.3 K (-6.77 %) |
| Jul 03 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 131.89 | 23,375 | 3,082,929 | 70,074 | 46.7 K to 70.1 K (+50.05 %) |
| Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
| Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 109.14 | 4,250 | 463,845 | 12,750 | |
| Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 160.00 | 4,250 | 680,000 | 46,699 | 50.9 K to 46.7 K (-8.34 %) |
| Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 109.14 | 4,250 | 463,845 | 50,949 | 46.7 K to 50.9 K (+9.10 %) |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 13.80 | 15,000 | 207,000 | 0 | |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 25.45 | 10,000 | 254,500 | 0 | |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 31.42 | 25,000 | 785,568 | 0 | 25 K to 0 (-100.00 %) |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 13.80 | 15,000 | 207,000 | 25,000 | 10 K to 25 K (+150.00 %) |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 25.45 | 10,000 | 254,500 | 10,000 | 0 to 10 K |
| Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.75 | 4,000 | 7,000 | 4,000 | |
| Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
| Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Grant | A | 1.75 | 22,857 | 40,000 | 45,845 | 23 K to 45.8 K (+99.43 %) |
| May 16 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 155.78 | 217 | 33,804 | 46,699 | 46.9 K to 46.7 K (-0.46 %) |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 20.16 | 10,000 | 201,600 | 0 | |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 23.86 | 6,323 | 150,897 | 0 | 6.3 K to 0 (-100.00 %) |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 23.46 | 3,677 | 86,277 | 6,323 | 10 K to 6.3 K (-36.77 %) |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 20.16 | 10,000 | 201,600 | 10,000 | 0 to 10 K |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | A | 155.57 | 19,566 | 3,043,883 | 19,566 | |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Grant | A | 0.00 | 8,437 | 0 | 64,495 | 56.1 K to 64.5 K (+15.05 %) |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Grant | A | 0.00 | 15,170 | 0 | 56,058 | 40.9 K to 56.1 K (+37.10 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 96.87 | 2,125 | 205,849 | 4,250 | |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 159.29 | 500 | 79,645 | 40,888 | 41.4 K to 40.9 K (-1.21 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 158.11 | 400 | 63,244 | 41,388 | 41.8 K to 41.4 K (-0.96 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 157.02 | 400 | 62,808 | 41,788 | 42.2 K to 41.8 K (-0.95 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 155.80 | 825 | 128,535 | 42,188 | 43 K to 42.2 K (-1.92 %) |
| Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | M | 96.87 | 2,125 | 205,849 | 43,013 | 45.1 K to 43 K (-4.71 %) |
| Nov 17 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 147.29 | 7 | 1,031 | 40,888 | 40.9 K to 40.9 K (-0.02 %) |
| Nov 07 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 77.31 | 4,250 | 328,568 | 4,250 | |
| Nov 07 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 91.05 | 2,155 | 196,213 | 19,397 | |
| Nov 07 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 150.00 | 4,250 | 637,500 | 40,888 | 45.1 K to 40.9 K (-9.42 %) |
| Nov 07 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 77.31 | 4,250 | 328,568 | 45,138 | 40.9 K to 45.1 K (+10.39 %) |
| Nov 07 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 150.00 | 2,155 | 323,250 | 40,888 | 43 K to 40.9 K (-5.01 %) |
| Nov 07 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 91.05 | 2,155 | 196,213 | 43,043 | 40.9 K to 43 K (+5.27 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 149.34 | 200 | 29,868 | 40,888 | 41.1 K to 40.9 K (-0.49 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 148.26 | 3,791 | 562,054 | 41,088 | 44.9 K to 41.1 K (-8.45 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 147.40 | 3,500 | 515,900 | 44,879 | 48.4 K to 44.9 K (-7.23 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 146.39 | 5,200 | 761,228 | 48,379 | 53.6 K to 48.4 K (-9.71 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 145.26 | 22,464 | 3,263,121 | 53,579 | 76 K to 53.6 K (-29.54 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 144.47 | 32,945 | 4,759,564 | 76,043 | 109 K to 76 K (-30.23 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 143.47 | 5,200 | 746,044 | 108,988 | 114.2 K to 109 K (-4.55 %) |
| Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 142.40 | 1,700 | 242,080 | 114,188 | 115.9 K to 114.2 K (-1.47 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 96.87 | 2,125 | 205,849 | 6,375 | |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 157.07 | 200 | 31,414 | 115,888 | 116.1 K to 115.9 K (-0.17 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 156.24 | 850 | 132,804 | 116,088 | 116.9 K to 116.1 K (-0.73 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 155.03 | 875 | 135,651 | 116,938 | 117.8 K to 116.9 K (-0.74 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 154.01 | 200 | 30,802 | 117,813 | 118 K to 117.8 K (-0.17 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 96.87 | 2,125 | 205,849 | 118,013 | 115.9 K to 118 K (+1.83 %) |
| Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 77.31 | 4,250 | 328,568 | 8,500 | |
| Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 156.02 | 1,250 | 195,025 | 115,888 | 117.1 K to 115.9 K (-1.07 %) |
| Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 155.29 | 2,600 | 403,754 | 117,138 | 119.7 K to 117.1 K (-2.17 %) |
| Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 154.09 | 400 | 61,636 | 119,738 | 120.1 K to 119.7 K (-0.33 %) |
| Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 77.31 | 4,250 | 328,568 | 120,138 | 115.9 K to 120.1 K (+3.67 %) |
| Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 91.05 | 2,155 | 196,213 | 21,552 | |
| Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 156.09 | 455 | 71,021 | 115,888 | 116.3 K to 115.9 K (-0.39 %) |
| Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 154.55 | 700 | 108,185 | 116,343 | 117 K to 116.3 K (-0.60 %) |
| Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 153.57 | 500 | 76,785 | 117,043 | 117.5 K to 117 K (-0.43 %) |
| Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 152.49 | 500 | 76,245 | 117,543 | 118 K to 117.5 K (-0.42 %) |
| Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 91.05 | 2,155 | 196,213 | 118,043 | 115.9 K to 118 K (+1.86 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 83.36 | 2,125 | 177,140 | 0 | |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 154.13 | 100 | 15,413 | 115,888 | 116 K to 115.9 K (-0.09 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 153.30 | 1,100 | 168,630 | 115,988 | 117.1 K to 116 K (-0.94 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 152.24 | 925 | 140,822 | 117,088 | 118 K to 117.1 K (-0.78 %) |
| Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 83.36 | 2,125 | 177,140 | 118,013 | 115.9 K to 118 K (+1.83 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 83.36 | 31,875 | 2,657,100 | 2,125 | |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 77.31 | 55,250 | 4,271,378 | 12,750 | |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 91.05 | 10,775 | 981,064 | 23,707 | |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 96.87 | 25,500 | 2,470,185 | 8,500 | |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 162.40 | 200 | 32,480 | 115,888 | 116.1 K to 115.9 K (-0.17 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 161.71 | 5,106 | 825,691 | 116,088 | 121.2 K to 116.1 K (-4.21 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 161.01 | 2,000 | 322,020 | 121,194 | 123.2 K to 121.2 K (-1.62 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 159.61 | 815 | 130,082 | 123,194 | 124 K to 123.2 K (-0.66 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 158.62 | 1,829 | 290,116 | 124,009 | 125.8 K to 124 K (-1.45 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 157.56 | 400 | 63,024 | 125,838 | 126.2 K to 125.8 K (-0.32 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 161.00 | 123,400 | 19,867,400 | 126,238 | 249.6 K to 126.2 K (-49.43 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 83.36 | 31,875 | 2,657,100 | 249,638 | 217.8 K to 249.6 K (+14.64 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 77.31 | 55,250 | 4,271,378 | 217,763 | 162.5 K to 217.8 K (+34.00 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 91.05 | 10,775 | 981,064 | 162,513 | 151.7 K to 162.5 K (+7.10 %) |
| Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 96.87 | 25,500 | 2,470,185 | 151,738 | 126.2 K to 151.7 K (+20.20 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 38.80 | 10,195 | 395,566 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 51.75 | 9,062 | 468,959 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 37.86 | 23,789 | 900,652 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 48.74 | 18,124 | 883,364 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 45.11 | 37,383 | 1,686,347 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 124.00 | 98,553 | 12,220,572 | 126,238 | 224.8 K to 126.2 K (-43.84 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 38.80 | 10,195 | 395,566 | 224,791 | 214.6 K to 224.8 K (+4.75 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 51.75 | 9,062 | 468,959 | 214,596 | 205.5 K to 214.6 K (+4.41 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 37.86 | 23,789 | 900,652 | 205,534 | 181.7 K to 205.5 K (+13.09 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 48.74 | 18,124 | 883,364 | 181,745 | 163.6 K to 181.7 K (+11.08 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 45.11 | 37,383 | 1,686,347 | 163,621 | 126.2 K to 163.6 K (+29.61 %) |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| May 26 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.74 | 4,000 | 6,960 | 4,000 | |
| May 26 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.74 | 20,000 | 34,800 | 20,000 | |
| May 26 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Grant | A | 1.74 | 22,988 | 39,999 | 22,988 | 0 to 23 K |
| May 17 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 114.92 | 294 | 33,786 | 126,238 | 126.5 K to 126.2 K (-0.23 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 87.66 | 3,842 | 336,790 | 130,080 | 133.9 K to 130.1 K (-2.87 %) |
| Jan 09 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
| Aug 04 2016 | OPHT | Ophthotech Corp. | SMITH IAN F | Director | Option Exercise | A | 62.63 | 20,000 | 1,252,600 | 20,000 | |
| Jun 21 2016 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.52 | 4,000 | 6,080 | 4,000 | |
| Jun 21 2016 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| May 18 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 82.06 | 202 | 16,576 | 112,999 | 113.2 K to 113 K (-0.18 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 91.05 | 34,482 | 3,139,586 | 34,482 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 92.73 | 1,652 | 153,190 | 112,999 | 114.7 K to 113 K (-1.44 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 91.68 | 1,200 | 110,016 | 114,651 | 115.9 K to 114.7 K (-1.04 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 90.97 | 4,232 | 384,985 | 115,851 | 120.1 K to 115.9 K (-3.52 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 89.90 | 5,000 | 449,500 | 120,083 | 125.1 K to 120.1 K (-4.00 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 17,299 | 173 | 125,083 | 107.8 K to 125.1 K (+16.05 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 18.21 | 10,000 | 182,100 | 0 | |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 17.85 | 2,689 | 47,999 | 0 | |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 22.13 | 542 | 11,994 | 0 | |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 42.26 | 100 | 4,226 | 0 | 100 to 0 (-100.00 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 41.85 | 13,131 | 549,480 | 100 | 13.2 K to 100 (-99.24 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 18.21 | 10,000 | 182,100 | 13,231 | 3.2 K to 13.2 K (+309.50 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 17.85 | 2,689 | 47,999 | 3,231 | 542 to 3.2 K (+496.13 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 22.13 | 542 | 11,994 | 542 | 0 to 542 |
| Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 126.62 | 2,685 | 339,975 | 107,784 | 110.5 K to 107.8 K (-2.43 %) |
| Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 125.98 | 4,865 | 612,893 | 110,469 | 115.3 K to 110.5 K (-4.22 %) |
| Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 124.95 | 2,800 | 349,860 | 115,334 | 118.1 K to 115.3 K (-2.37 %) |
| Jul 23 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 131.89 | 34,000 | 4,484,260 | 34,000 | |
| Jun 16 2015 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 11.06 | 4,000 | 44,240 | 4,000 | |
| Jun 16 2015 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| May 18 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 126.99 | 100 | 12,699 | 118,134 | 118.2 K to 118.1 K (-0.08 %) |
| May 18 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 125.84 | 178 | 22,400 | 118,234 | 118.4 K to 118.2 K (-0.15 %) |
| May 18 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 123.85 | 100 | 12,385 | 118,412 | 118.5 K to 118.4 K (-0.08 %) |
| Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 127.83 | 500 | 63,915 | 118,134 | 118.6 K to 118.1 K (-0.42 %) |
| Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 126.65 | 1,000 | 126,650 | 118,634 | 119.6 K to 118.6 K (-0.84 %) |
| Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 125.69 | 2,815 | 353,817 | 119,634 | 122.4 K to 119.6 K (-2.30 %) |
| Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 124.87 | 1,327 | 165,702 | 122,449 | 123.8 K to 122.4 K (-1.07 %) |
| Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 123.52 | 200 | 24,704 | 123,776 | 124 K to 123.8 K (-0.16 %) |
| Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 122.44 | 200 | 24,488 | 123,976 | 124.2 K to 124 K (-0.16 %) |
| Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 38.80 | 54,375 | 2,109,750 | 54,375 | |
| Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 12,084 | 121 | 39,877 | 27.8 K to 39.9 K (+43.48 %) |
| Jan 26 2011 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 40.71 | 6,042 | 245,970 | 27,793 | 33.8 K to 27.8 K (-17.86 %) |
| Jan 25 2011 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 39.93 | 6,042 | 241,257 | 33,835 | 39.9 K to 33.8 K (-15.15 %) |
| Nov 16 2010 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 34.47 | 77 | 2,654 | 39,877 | 40 K to 39.9 K (-0.19 %) |
| Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 33.82 | 36,250 | 1,225,975 | 36,250 | |
| May 19 2010 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 37.68 | 774 | 29,164 | 39,877 | 40.7 K to 39.9 K (-1.90 %) |
| May 10 2010 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 36.16 | 9,131 | 330,177 | 39,877 | 49 K to 39.9 K (-18.63 %) |
| May 10 2010 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 35.72 | 5,869 | 209,641 | 49,008 | 54.9 K to 49 K (-10.69 %) |
| Apr 06 2010 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 40.75 | 18,242 | 743,362 | 54,877 | 73.1 K to 54.9 K (-24.95 %) |